These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1454203)

  • 1. L-threo-3,4-dihydroxyphenylserine enhanced ocular dominance plasticity in adult cats.
    Mataga N; Imamura K; Watanabe Y
    Neurosci Lett; 1992 Aug; 142(2):115-8. PubMed ID: 1454203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of mRNA expression of tissue-type plasminogen activator by L-threo-3,4-dihydroxyphenylserine in association with ocular dominance plasticity.
    Mataga N; Imamura K; Shiomitsu T; Yoshimura Y; Fukamauchi K; Watanabe Y
    Neurosci Lett; 1996 Nov; 218(3):149-52. PubMed ID: 8945750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
    Sasa M; Ohno Y; Nabatame H; Yoshimura N; Takaori S
    Brain Res; 1987 Sep; 420(1):157-61. PubMed ID: 3119149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
    Hirose A; Sasa M; Ohno Y; Takaori S
    Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
    Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
    Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
    Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
    J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular dominance plasticity restored by NA infusion to aplastic visual cortex of anesthetized and paralyzed kittens.
    Imamura K; Kasamatsu T
    Exp Brain Res; 1991; 87(2):309-18. PubMed ID: 1769385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W; Nakahara D; Naoi M
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-threo-DOPS, a noradrenaline precursor, on the long-term potentiation in the rat hippocampal mossy fiber-CA3 region.
    Sakai N; Sasa M; Ishihara K; Komure O; Tanaka C; Takaori S
    Brain Res; 1991 Dec; 567(2):267-73. PubMed ID: 1817730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Kunimoto M; Saito M
    J Auton Nerv Syst; 1992 Jun; 39(2):159-67. PubMed ID: 1430796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Mizoguchi K; Tanaka M; Yokoo H; Yoshida M; Tsuda A
    Experientia; 1992 Dec; 48(11-12):1133-4. PubMed ID: 1473578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P
    Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.